Are new drugs for schizophrenia better than old ones? - Authors' reply

Stefan Leucht, Werner Kissling, Rolf R. Engel, John M. Davis

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{0e1618bd155348b0aeb019cfdc491460,

title = "Are new drugs for schizophrenia better than old ones? - Authors' reply",

author = "Stefan Leucht and Werner Kissling and Engel, {Rolf R.} and Davis, {John M.}",

year = "2009",

doi = "10.1016/S0140-6736(09)60723-6",

language = "English",

volume = "373",

pages = "1249--1250",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "9671",

}

TY - JOUR

T1 - Are new drugs for schizophrenia better than old ones? - Authors' reply

AU - Leucht, Stefan

AU - Kissling, Werner

AU - Engel, Rolf R.

AU - Davis, John M.

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=85102088530&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(09)60723-6

DO - 10.1016/S0140-6736(09)60723-6

M3 - Letter

AN - SCOPUS:85102088530

SN - 0140-6736

VL - 373

SP - 1249

EP - 1250

JO - The Lancet

JF - The Lancet

IS - 9671

ER -